M Vignali

No ORCID on file · 104 papers in corpus · active 1991-2026

Study types

  • article 78
  • review 13
  • other 10
  • letter 2
  • erratum 1

Condition tags

  • endometriosis 76
  • mesh:D004715 52
  • endometrioma 14
  • mesh:D017699 9
  • dysmenorrhea 7
  • chronic_pelvic_pain 4
  • adenomyosis 4
  • dyspareunia 3
  • mesh:D004412 2
  • mesh:D004414 2
article 2026
·doi:10.36129/jog.2026.258

Endometriosis entails a huge burden: it is estimated that affects 10% of women in their reproductive age.Symptoms may be severe (chronic pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia and fatigue) affecting women's quality of li…

article 2026
·doi:10.1093/humupd/dmag011

Endometriosis, particularly ovarian endometrioma, is associated with a 2-fold increased risk of ovarian cancer (OC), especially the clear cell and endometrioid subtypes. However, the absolute lifetime risk of OC in women with endometriosis …

review 2026
Human reproduction open ·doi:10.1093/hropen/hoaf064

STUDY QUESTION: Are endometriotic lesions affecting bilateral organs or anatomical structures distributed symmetrically on both sides of the body? SUMMARY ANSWER: The left-sided preponderance of pelvic endometriotic lesions, and the right-…

review 2026
Journal of clinical medicine ·doi:10.3390/jcm15062408

Endometriosis is associated with nociceptive pain, as well as peripheral and central sensitization. Evidence-based treatment suggestions for controlling endometriosis should be based on the convergence of the best scientific evidence, physi…

other 2026
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2026.2659439

OBJECTIVE: To evaluate the clinical efficacy and safety of a once-daily oral fixed-dose combination of relugolix 40 mg, estradiol 1 mg, and norethisterone acetate 0.5 mg in women with symptomatic adenomyosis coexisting with uterine fibroids…

review 2024
Expert opinion on drug metabolism & toxicology ·doi:10.1080/17425255.2024.2441981

INTRODUCTION: In ovarian steroid-dependent diseases such as uterine fibroids, endometriosis and adenomyosis, oral GnRH antagonists have emerged as new therapeutic alternatives. These oral GnRH antagonists offer key advantages, including ora…

review 2024
Journal of clinical medicine ·doi:10.3390/jcm13113302

Background/Objectives: Adenomyosis is a benign condition characterized by the presence of endometrial tissue within the myometrium. Despite surgery being a valuable approach, medical options are considered as the first-line approach and hav…

article 2023
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.15.1.059

Uterine fibroids have an impact on women's lives due to their high prevalence, physical symptoms, their consequences on patients' emotional and psychological well-being and loss of work productivity. The choice of therapeutical approaches v…

article 2022
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2022.2128644

Purpose The aim of the study was to assess the length of diagnostic delay of symptomatic endometriosis in Italy and analyse the presence of correlations between the socio-demographic status of patients and the clinical characteristics/type …

article 2022
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13602

PROBLEM: Starting from November 2019, the world has had to face a devastating pandemic caused by SARS-CoV-2. Various studies have identified potential risk factors facilitating the infection, however it has not been demonstrated whether end…

article 2022
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2022.05.001
other 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06243-z

PURPOSE: To evaluate obstetric outcome in women with endometriosis who conceive naturally and receive standard obstetric care in Italy. METHODS: Cases were consecutive women with endometriosis managed in eleven Italian referral centers. Co…

article 2022
PloS one ·doi:10.1371/journal.pone.0271173

The management of endometriosis-related infertility is still a challenging issue. Women can be managed with either surgery or in vitro fertilization (IVF). The decision is tailored to the patients considering pros and cons of both approache…

article 2021
Minerva endocrinology ·doi:10.23736/s2724-6507.20.03298-8

BACKGROUND: Combined oral contraceptives (COCs) represent a common pharmacological approach for endometriosis. They have been demonstrated to mitigate painful symptoms in patients and are considered the first line therapy for symptomatic di…

review 2021
·doi:10.1136/bmjopen-2020-048190

OBJECTIVE: To summarise the available evidence on frequency of ovarian cyst development during mammalian target of rapamycin inhibitors (mTORi) treatment. METHODS: PubMed/Medline and EMBASE databases were searched, from 1990 up to March 202…

article 2020
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2020.1725965

Studies have been published on the efficacy of Dienogest in the management of pain symptoms in endometriosis. Nonetheless, few data are available on the reducing effect on endometrioma’s size. The aim of the study was to evaluate if Dienoge…

article 2020
·doi:10.5256/f1000research.25002.r66784
review 2020
Current medical research and opinion ·doi:10.1080/03007995.2020.1744120

Overall, the evidence demonstrates that dienogest offers an effective and tolerable alternative or adjunct to surgery and provides many advantages over combined hormonal contraceptives for the treatment of endometriosis. It is important tha…

review 2019
Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697137.2018.1549213

The incidence of endometriosis in middle-aged women is not minimal compared to that in the reproductive age group. The treatment of affected women after childbearing age to the natural transition toward menopause has received considerably p…

article 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2019.1640674

Ovarian endometriomas are common manifestations of endometriosis. Surgical excision has been shown to potentially decrease ovarian reserves. In this prospective study, we included 81 patients with ovarian endometriosis. 40 were treated with…

article 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2019.1640199

The aim of the present study was to evaluate the effect of medical treatment of ovarian endometriomas on cyst diameter, associated pain, and ovarian reserve as measured with antral follicle count (AFC) and anti-Mullerian hormone (AMH). In t…

article 2019
Human reproduction open ·doi:10.1093/hropen/hoz009

A network of endometriosis experts from 16 Italian academic departments and teaching hospitals distributed all over the country made a critical appraisal of the available evidence and definition of 10 suggestions regarding measures to be de…

article 2018
·doi:10.14660/2385-0868-85
article 2018
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2018.11.012
article 2015
Human Reproduction ·doi:10.1093/humrep/dev313

STUDY QUESTION: Is the combined excisional/ablative technique for the treatment of ovarian endometriomas better than the traditional stripping technique in terms of recurrence rate? SUMMARY ANSWER: There is no evidence that the combined exc…